1. Home
  2. DXCM vs EL Comparison

DXCM vs EL Comparison

Compare DXCM & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • EL
  • Stock Information
  • Founded
  • DXCM 1999
  • EL 1946
  • Country
  • DXCM United States
  • EL United States
  • Employees
  • DXCM N/A
  • EL N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • EL Package Goods/Cosmetics
  • Sector
  • DXCM Health Care
  • EL Consumer Discretionary
  • Exchange
  • DXCM Nasdaq
  • EL Nasdaq
  • Market Cap
  • DXCM 28.0B
  • EL 28.8B
  • IPO Year
  • DXCM 2005
  • EL 1995
  • Fundamental
  • Price
  • DXCM $77.72
  • EL $79.31
  • Analyst Decision
  • DXCM Buy
  • EL Hold
  • Analyst Count
  • DXCM 17
  • EL 20
  • Target Price
  • DXCM $101.29
  • EL $89.22
  • AVG Volume (30 Days)
  • DXCM 3.9M
  • EL 5.2M
  • Earning Date
  • DXCM 02-06-2025
  • EL 10-31-2024
  • Dividend Yield
  • DXCM N/A
  • EL 1.76%
  • EPS Growth
  • DXCM 83.21
  • EL N/A
  • EPS
  • DXCM 1.67
  • EL 0.56
  • Revenue
  • DXCM $3,954,000,000.00
  • EL $15,451,000,000.00
  • Revenue This Year
  • DXCM $13.10
  • EL N/A
  • Revenue Next Year
  • DXCM $14.79
  • EL $3.99
  • P/E Ratio
  • DXCM $46.61
  • EL $141.18
  • Revenue Growth
  • DXCM 16.19
  • EL N/A
  • 52 Week Low
  • DXCM $62.34
  • EL $62.29
  • 52 Week High
  • DXCM $142.00
  • EL $159.75
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 56.89
  • EL 61.07
  • Support Level
  • DXCM $77.50
  • EL $77.25
  • Resistance Level
  • DXCM $82.26
  • EL $76.42
  • Average True Range (ATR)
  • DXCM 2.42
  • EL 2.54
  • MACD
  • DXCM 0.20
  • EL 2.09
  • Stochastic Oscillator
  • DXCM 53.44
  • EL 90.34

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About EL Estee Lauder Companies Inc. (The)

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Share on Social Networks: